Anti obesity pill gets EURO nod

by Medindia Content Team on  May 1, 2006 at 7:28 PM Obesity News
RSS Email Print This Page Comment
Anti obesity pill gets EURO nod
As an impetus to the weight loss industry a panel comprising European experts recommended Sanofi-Aventis's anti-obesity pill Acomplia be approved for sales in the European Union. This news was brought to light by the company itself.
Advertisement

The action of the pill Acomplia (rimonabant) is to block a pleasure centre and so fight obesity. People on the pill eat less because they feel less pleasure associated with eating.

Advertisement
Data from a trial involving more than 6,600 patients worldwide was used for the recommendation. The trial showed that patients taking Acomplia 20 mg per day lost 7.5 kg for a two-year period. It also improved waist circumference, HbA1c, HDL cholesterol and blood fat.

The European Union will make its decision within two to three months to decide whether Acomplia can be sold in Europe.

Sanofi says in its news release, "Following European marketing authorization, Acomplia will be available in European Union countries for prescription as a 20mg tablet to be taken once daily. First launches are anticipated during the second half of 2006."

So European markets would hopefully soon find this pill sold to public.
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Bariatric Surgery Obesity Vasectomy Binge Eating : The Pleasure and Pain Bulimia Nervosa Body Mass Index Liposuction Battle of the Bulge Diabesity Hunger Fullness and Weight Control 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive